Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination product contains **lactulose**, a synthetic disaccharide laxative; **vitamin D** (typically as cholecalciferol or D3); and **calcium** (often as calcium gluconate). It is primarily marketed in specific regions, such as India, as a therapeutic supplement to manage chronic constipation while simultaneously addressing calcium and vitamin D deficiencies. Lactulose acts as an osmotic laxative by increasing the water content and volume of stools in the colon and is also used to reduce blood ammonia levels in hepatic encephalopathy. Calcium and vitamin D3 are included to support bone mineral density and skeletal health, particularly in elderly patients or those with chronic conditions where both constipation and bone loss are common comorbidities. The product is typically formulated as an oral solution or syrup.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactulose + vitamin D + calcium.